Trial Profile
Actemra All-Patient, Long-Term Special Drug Use Surveillance
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant lymph node hyperplasia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 14 Jul 2016 New trial record